When tumor cells express PD-L1 to combine with the PD-1 provided by tumor-infiltrating lymphocytes, the immune effect of T cells in the tumorous microenvironment is inhibited, which mediates the occurrence of tumor immune escape and promotes the progress of cancer [25]. Here, CD274 is linked to neoplasm.